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The aim of this thesis was to characterize, clone and express $** gene
product for structural studies either on its or own together with beta and alpha subunits.
The $** gene coding for the $UDELGRSVLV WKDOLDQD G protein gamma
subunit was amplified by PCR and subcloned in (FROL for verification and analyses of
the cDNA sequence. Following source sequence verification $** was inserted into
different expression vector for overexpression of the recombinant protein. These vectors
included pGEX-4T2, pGFPuv, pTrcHis-TOPO and pT7/NT-TOPO. Different E. coli
strains including BL21(DE3) and BL21(DE3)pLysS, were tried as host cells.
Expression of AGG1-his tag fusion protein using pTrcHis-TOPO in BL21(DE3)pLysS
cells was demonstrated. AGG1 protein was detected by Western blotting and coomassie
blue staining of polyacrylamide gels.
This study is the first report of AGG1 expression and synthesis of the gene
product in a bacterial cell and it provides characterization of different $** gene
containing constructs. Further work is needed for more efficient expression of AGG1 in
other host systems.
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Bu projenin amac  AGG1 geninin klonlanmas , karakterizasyonu ve yap  çal  mal 
için tek ba  na veya alfa ve beta altbirimleri ile birlikte ekspresyonudur.$ WKDOLDQD G proteini gamma alt birimi proteinini sentezleyen AGG1 geni polimeraz
zincir reaksiyonu ile ço alt l p cDNA sekans n n verifikasyonu ve analizi amac yla (FROL hücrelerine  klonlanm  t r. Verifikasyonu takiben AGG1 geni, rekombinant
proteinin yüksek miktarda üretimi için farkl  ekspresyon vektörlerine yerle tirilmi tir.
Bu vektörler pGEX-4T2, pGFPuv, pTrcHis-TOPO and pT7/NT-TOPO vektörleridir.
Farkl  E. coli tipleri olan BL21(DE3) and BL21(DE3)pLysS konak hücre olarak
kullan lm  t r. AGG1-his i retli proteininin sentezi pTrcHis-TOPO vektörü kullan larak
BL21(DE3)pLysS tipi hücrelerde gösterilmi tir. AGG1 proteini Western transfer
yöntemiyle ve Komassi boyama ile poliakrilamid jeller üzerinde gösterilmi tir.
Bu çal  ma $** geninin ekspresyonunu ve gen ürünü olan proteinin bakteri
hücrelerinde sentezini göstermesi aç s ndan ilktir ve $** geninin farkl  vektörlere
yerle tirilerek karakterizasyonu sa lanm  t r. $** geninin daha verimli
ekspresyonunu sa lamak için farkl  canl  sistemlerin de denenmesi gerekmektedir.
To my family
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ABA: Abscisic acid
AC: Adenylyl cyclase
$**: First identified G gene from $7KDOLDQD
AGG2: Second identified G gene from $7KDOLDQD
AGS: Activator of G protein Signalling
ATP: Adenosine triphosphate
cGMP: Cyclic GMP
C-terminus: Carboxyl terminus
Cys: Cysteine amino-acid
GAP: GTPase activity
G.: G-protein alpha subunit
G: G-protein beta subunit
GDP: Guanosine di-phosphate
G: G-protein gamma subunit
2GNEF: Guanine nucleotide exchange factor
GP.1: G. gene from $7KDOLDQD
GPCR: G-protein coupled receptor
GTP: Guanosine tri-phosphate
GTPase: enzyme converting GTP into GDP
G.-GDP: G. bound to GDP, in its active site
G.-GTP: G. bound to GTP, in its active site
DAG: Diacylglycerol
EF: Elongation Factor
FR: far-red
IP3: Phosphotidylinositol 3-kinase
NMR: Nuclear magnetic resonance
N-terminus: Amino terminus
PLA: Phospholipase-A
PLC: Phospholipase-C
PhyA: Phytochrome A
Phy B: Phytochrome B
3RGS: regulators of G-protein signaling
SA: Salicilic acid
TAIR: $UDELGRSVLVWKDOLDQD web page (www.arabidopsis.org)
WD40 repeat: Tryptophane-Aspartate repeate consisting of 40 residues
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   Heterotrimeric GTP-binding proteins (G proteins) consist of three subunits; .,
and , and function as major signaling elements between G protein coupled receptors
(GPCRs) at membranes and intracellular effectors.  They have been shown to be key
mediators of many important cellular functions such as vesicular transport, multi-drug
resistance, cell signaling, phagocytosis, endocytosis, neurotransmitter release, and cell
migration to name just a few.
   Based on a structural classification, small GTP-binding proteins and elongation
factors, along with the Heterotrimeric G proteins make up the three forms of Guanine
nucleotide binding proteins.
   Small GTP-binding proteins are members of the Ras superfamily, which is
divided into Ras, Rho, Rab, Arf and Ran families. Their active form, which binds GTP,
interacts with cellular effectors to which they transmit signals of action. The activity of
small GTP-binding is controlled  by three main classes of proteins, which regulate the
alternation between their inactive, GTP-bound form, and their active form: i) Guanine
nucleotide exchange factors or GEFs, which activate small GTP-binding proteins by
stimulating the dissociation of the tightly bound GDP nucleotide; ii) GTPase Activating
Proteins or GAPs, which terminate the signal by stimulating the hydrolysis of GTP; iii)
Guanine Nucleotide Dissociation Inhibitors or GDIs, which partition the Rho and Rab
subfamilies between membranes and cytosol. Plant homologues of these proteins are
classified as Ras, Raf, Arf and ROP.
5   The protein synthesis elongation factors EF-Tu and EF-G make up the other class
of GTP binding proteins. The GTP-bound form of EF-Tu brings the amino acid carrying
tRNA to the ribosome while GTP-bound EF-G catalyzes the translocation of amino acid
from the A to P site of the ribosome. EF-Tu was the first G-protein whose nucleotide
binding domain was solved structurally by X-ray crystallography to yield a structural
definition of the GDP-bound form.
   Unlike small GTPases, being composed of a single GTP-binding domain,
heterotrimeric G proteins are composed of three subunits: a GTP-binding domain (.
subunit),  subunit and  subunit. Under conditions of no ligand binding to GPCRs, the
three subunits stay in a complexed form at the interior part of the membrane. Ligand
binding to receptor parts accessible from outside the cell results in changes in
heterotrimeric G-proteins attached to the inside of the cell plasma membranes. These
changes include exchange of an alpha subunit bound guanine diphosphate (GDP) for a
guanine triphosphate (GTP). The alpha subunit with bound GTP dissociate from beta-
gamma complex and associate, separately, with other intracellular biomolecules
including phosphodiesterase, adenylyl cyclase, and phospholipase that regulate the
formation of cellular second messengers. Recently, 13 alpha, 7 beta and 2 gamma
subunits were identified in plant systems.
   The function of a protein is absolutely dependent on its 3-D structure. Hence,
efficient crystallization and structure analysis of heterotrimeric G proteins using small
angle scattering will be the only way to understand their functional characteristics.
GPCRs or G protein-dependent signaling pathways are the targets of a very large
number of therapeutically useful drugs. Detailed knowledge about the molecular
structure of the elements of G protein signaling pathways should therefore open the gate
for the design of novel drugs with increased efficacy and specificity for both humans
and plants. However, like every recombinant protein, the protein of interest should be
cloned efficiently and expressed under optimal conditions in a suitable organism in high
amounts for structural studies and other purposes.
6   This study is performed in order to clone, express and characterize $UDELGRSVLVWKDOLDQDG protein gamma subunit (AGG1), for determining its structural features and
comparing with mammalian counterparts.
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   GPCRs, share the general structure of 7 transmembrane helices which are
connected by three intracellular and three extracellular loops (Baldwin HW DO., 1993).
These regions provide specific functions to these receptor proteins. The signal
transduction mechanism related with the G protein coupled receptors is dedicted to
certain stimulating factors including light, Ca2+ ions, taste ligands, and small molecules
such as amino acids, nucleotides and peptides.
   Despite the common structural characteristics, GPCRs have various nucleotide
differences among species, resulting in different domains to bind their ligands and
activate G proteins. GPRCs are a very diverse group membrane receptor proteins whose
members heve distinct sequences and these sequences meke up a relatively high
percentage of the total genome of most organisms; i.e. 5% in C. elegans (Joel and Jean,
1999) and 1% in human (Marinissen HWDO., 2001).
   As shown in figure 1.1, among the three cytoplasmic loops, I2 and I3 loops are
critical in G protein recognition and activation. Based on the studies of rhodopsin
structure, the change from inactive to active state is achieved with a change in the
relative orientation of transmembrane helices 3 and 6, which unmasks G protein binding
sites (Joel and Jean, 1999). This is necessarily a consequence of ligand binding; and
association of GPCR in this conformation with G proteins promotes the exchange of
GDP for GTP at G alpha subunit and triggers the separation of  dimer from . (Hur HWDO., 2002). Also a ligand-induced conformational change at the COOH terminus of alpha
8subunit may result in a reduced binding and dissociation from the complex (Yang HWDO.,
1999). Recently, homo- or hetero-dimerization of GPCRs via their sixth transmembrane
helices has been proposed instead of one receptor-one G protein view. This dimerization
could be important for activation of G proteins. Additionally, palmitoylations at
conserved Cys residues and phosphorylations at Ser residues could direct and modify
the coupling specificity of GPCRs (Joel and Jean, 1999).
Figure 2.1 GPCR signalling pathways (Marinissen HWDO., 2001)
   In plants, specifically $WKDOLDQD, there is no receptor complex that is proved to
interact directly with G proteins. However, there are some candidates among which
MLO1 is the most studied candidate, despite the mechanism of action is unknown. In
addition, GCR1 shares some sequence identities with the animal GPCR members
rhodopsin7serotonin family (Alan, 2002).
9 5HFHSWRU,QGHSHQGHQW*SURWHLQVLJQDOOLQJ
   Three proteins as the Activators of G protein Signalling (AGS1, AGS2 and
AGS3) were reported in 6DFFKDURP\FHV FHUHYLVDH, to function on heterotrimeric G
protein signaling in the absence of a receptor protein. Although the starting stimulus or
the mechanism of AGS1 activation, if any, is still to be solved; yeast protein assays
show that AGS1 and 3 preferentially bind to the . subunit while AGS2 interacts with
the  dimmer (Mary HWal., 2001). Moreover, AGS3 has been studied to be a guanine
dissociation inhibitor (GDI) which means that in interacts with the GDP-bound form of
G. to dissociate from  (De Vries HWDO., 2000). No plant counterpart of these proteins
has been identified yet.
Figure 2.2 Schematic representation of AGS proteins of yet unidentified signal
processing (Cismowski HWDO 2001)
 6PDOO*73ELQGLQJ3URWHLQV
   Ras superfamily is the group of small monomeric GTP binding proteins,
consisting of Ras, Rho, Rab, Arf and Ran families. Small GTPases recruitment can be
controlled by the action of Guanine Nucleotide Dissociation Inhibitor (GDI). GDI
10
activity in turn can be activated by cytoskeletal proteins. Ligation of growth factor
receptors or integrins leads to recruitment of Guanine Nucleotide exchange factor
(GEF) by post-translational modifications or binding phospholipids. Signal transduction
by activated Ras proteins is likely involve translocation of proteins to the membrane
compartment. Termination of signal transmission is also controlled at multiple levels,
including targeted degradation of GEFs through ubiquitination and stimulation of GTP
hydrolysis by GTPase activating proteins (GAPs) (Takai HWDO., 2001).
Figure 2.3 Small G protein superfamily (Takai HWDO., 2001)
   The complete activation of Ras-related proteins occurs via either the ARF-Gea2p
or Ras-SOS mechanisms. As the result, GTP should enter the nucleotide binding site
and dissociate the GEF. In both complexes, due to the open nucleotide site through the
solvent up to the .-phosphate group, GTP is allowed to enter by its GMP moiety
(Cherfils and Chardin, 1999). The return of Ras to its GDP-bound form makes Raf to
dissociate, activating MEK and MAP Kinase, to regulate gene expression by
phosphorylating transcription factors inside the nucleus (Hilgenfeld, 1995).
11
Figure 2.4 Signal Transduction downstream from Ras (Takai HWDO., 2001)
 (ORQJDWLRQ)DFWRUV
   The initiation of translation machinery requires participation of elongation factors
EF-Tu, EF-Ts and EF-G, among which EF-Tu and EF-G are small GTP binding
proteins. EF-Tu-GTP binds and delivers an aminoacyl-tRNA to the A site on the
ribosome. As the aa-tRNA is delivered by EF-Tu to the A site on the ribosome, GTP is
hydrolysed to GDP+Pi. A large conformational change occurs due to GTP hydrolysis
releasing EF-Tu, which in turn leads to repositioning of the aa-tRNA to promote peptide
bond formation. Translocation of the ribosome relative to mRNA involves the GTP
binding protein EF-G, attaching to the A site. This EF-G-GTP binding pushes the tRNA
with attached nascent polypeptide from the A site to the P site (Sprang, 1997).
12
Figure 2.5 Mechanism of EF activation (www.lebs.cnrs-gif.fr)
 +HWHURWULPHULF*SURWHLQV
 *HQHUDO,QIRUPDWLRQ
   Heterotrimeric GTP binding proteins (G proteins) play a central role in many
types of transmembrane signalling pathways by transmitting information from receptors
to effector molecules. G proteins are composed of .,  and  subunits having molecular
weights of ~45 kDa, ~35kDa and 7-10 kDa, respectively (Danner HWDO., 1996). Under
physiological conditions, the  and  subunits are tightly associated with each other and
are present as a dimer. The . subunit could be described as the major active site of the
heterotrimer, due to participating in a greater number of intracellular pathways than the dimer.
13
Figure 2.6 Heterotrimer
   The activation of the heterotrimer occurs by the binding of the ligand to a GPCR
protein, generally, and consequently with the reorientation of the domains of receptor
protein resulting in a different interaction power with the heterotrimer. This
rearrangement leads to an exchange of GDP with GTP on the  . subunit and
dissociation of . from . As much as 23 ., 6  and 12  subunits have been identified
in animals (Alan, 2002).
   In contrast to mammals and invertebrates, $WKDOLDQDgenome contains only one
G. (GPA1), one G (AGB1) and two G (AGG1-AGG2) (TAIR Homepage). The
existence and possible roles of each subunit together with the similarities with
mammalian counterparts will be discussed later.
14
 *SURWHLQ. VXEXQLW
   There are 4 classes of mammalian G protein alpha subunits, consisting altogether
of at least 23 proteins. These classes are: Gs (s-for stimulatory) activating adenylyl
cyclase; Gi (i-for inhibitory) inhibiting adenylate cyclase; Gq, for activating
phospholipase C (PL-C) and G12, for the regulation of small GTPases (Ma, 1994). The
alpha subunits have common structural domains including a Ras-like domain, an .-
helical domain which determines GDP release and an Asp-Glu rich loop. The latter two
are the ones that do not exist in small GTP binding proteins (Assmann, 2002). Until
now, only two of these mammalian G. subunits have been described. These stuructures;
Gt. and Gi.1 are both solved at their GTP and GDP bound states together with their
regulators RGS4. Gt. transduces the signal from rhodopsin to its effector molecule
cGMP phosphodiesterase while Gi.1 functions in the downregulation of adenylyl
cyclase (Bohm HWDO., 1997).
   The guanine nucleotide is kept at the contact of two major domains of the alpha
subunit; the Ras-like GTPase and the helical domain. There are three switches in the
GTPase domain which are conformationaly sensitive to the GTP or GDP bound state
and that form the interface between the subunit and  part. When GTP is bound, the
switch regions are kept in contact with the nucleotides third phosphate group. In the
GDP-bound state, the switches are flexible, reflecting their direct role in the .-
interaction (Bohm HWDO., 1997).
   The G protein alpha subunit interacts with a large number of effector molecules
including adenylyl cyclase, cGMP phosphodiesterase, phosphoinositide 3-kinase,
phospholipase D, Na+/H+ exchanger protein, transcription factor TUBBY, and
potassium, calcium, chloride and sodium channels (Assmann, 2002).
   The Arabidopsis genome contains only one identified alpha gene (GPA1). Also,
other homologs of GPA1 from several different plant species have been cloned and
expressed, which show sequence identities in the range of 34-42% with the mammalian
counterparts (Plakidou-Dymock HWDO., 1998).
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   A major effect of GPA1 in plants is related with its role in cell division. It is
reported to be highly expressed in meristematic tissues and the regulation of cell
division via alpha subunit is performed by its binding to some other downstream
proteins, specifically PLA 2, which is known to regulate cell proliferation in many cell
types (Capper and Marshall, 2001).
   Studies with tomato plants reveal that G protein alpha subunit may function,
although not proved structurally, on the regulation of ion channels. The open state
probability of Ca2+ channels in the membrane was shown to increase in TG.1
containing and GTPase deficient membranes (Aharon HWDO., 1998).
   K+ and Ca 2+ channels are among the most important downstream effectors. In
higher plants, regulation of stomatal opening is dependent on the concentration of  K+,
Cl -, malate2- and sucrose in the guard cells. Abscisic acid is a phytohormone that helps
water conservation in plants by decreasing the aperture of the stomatal pores in
epidermis and hence decreasing water loss. Wang HW DO., 2001 showed that, GPA1
mutant $ WKDOLDQD lacks both the ABA inhibition of the inward K+ channels and pH-
independent activation of ion channels. Therefore, water loss in these GPA1 mutants is
greater when compared with wild type plants.
 *SURWHLQ VXEXQLW
   Six mammalian isoforms of the G protein beta subunit have been described to
date. The most important structural feature of  is the overall 7 tandem repeats of WD-
40 motif and a conserved Trp-Asp (WD) motif (Assmann, 2002). Although this could
be defined as a general characteristic of the beta family, there are many other proteins
which contain the WD-40 motif and are not even related with the G protein  subunits.
Constitutive Photomorphogenic1 and Transparent Testa Glabra1 are only two examples
of this (Lease HW DO., 2001). But overall, the general 3-D structure of the  family of
16
proteins is defined as an N-terminus .-helical domain which is foollowed by a short
stretch of polypeptide chain linking it to the WD-40 motif (Hamm, 1998).
   There is one G protein beta subunit derived from the $WKDOLDQD genome (AGB1)
which shows 42% similarity to the mammalian G  subunits 2 and 3(Weiss HWDO., 1994).
It is known from structural studies that animal G subunits  are anchored to the cell
membranes via G subunits. It would be a disaster to think about a different mechanism,
other than the tight association between  and  subunits, for the plants but up to date
there is no structural study revealing the type and degree of association between  and 
subunits. However, in some of the studies it has been shown that G is a membrane-
associated protein in plants. G was highly rich in microsomal pellet, and when these
microsomes were treated with salts and detergents G was finally localized on the
membranes, attaching via hydrophobic interactions (Obrdlik HWDO., 2000).
   One mutant allele of AGB1, DJE constructed by Lease HWDO. resulted in a large
number of defects in $ WKDOLDQD including short fruits, rounded leaves and shortened
floral buds, demonstrating the possible role of the beta subunit on plant development.
 *SURWHLQ VXEXQLW
   Among the 12 mammalian G protein  subunits identified, a small size ranging
between 7-11 kDa,a prenyl group binding site on the C-terminus (CAAX box) and an
N-terminus coiled coil domain can be counted as general structural features. The most
important point to be considered is that,  and  are normally found as a dimer and they
cannot be separated except highly denaturing conditions. Therefore, the overall
conformation of the dimer could give an important view about the stuctures separately.
G is studied to form a coiled coil part with the N-terminus of G and continues
extending around the -propeller. This conformation makes the outer part of the
propeller positively charged, which is adjacent to the acyl-modificated part of G,
together making up the membrane-anchoring region of the heterotrimer (Bohm HW DO.,
1997).
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   The first plant G protein  subunits were identified, named AGG1 and AGG2 , in
2000 and 2001 respectively by Mason and Botella. These subunits show 48% sequence
identity to each other and 24-31% sequence identity to non-plant counterparts.
However, the common functional domains are almost identical among these, including
C-terminal and N-terminal regions. AGG1 and AGG2 are shown to interact with $WKDOLDQD  subunit (AGB1) using both yeast two-hybrid and in vitro binding assays.
Southern and Northern blotting studies sh owed that AGG1, just like AGG2, is a single-
copy gene, being expressed differentially in specific tissues.
   TGB1, which is the Tobacco G protein  subunit, to be used as bait, was cloned
into pAS-CYH vector and transferred into yeast. Retransformation was performed with
the $ WKDOLDQD yeast two hybrid library. Positive colonies possessing -Galactosidase
activity were isolated and a secondary screening was done by transforming yeast with
the library plasmid plus TGB1-pASCYH construct and the library plasmid plus another
plasmid being used as negative control. One positive clone, which is the AGG1 was
obtained several times, at the end of yeast two-hybrid protocols.
   For in vitro binding assay, recombinant vector containing AGG1-GST fusion
sequence was constructed, expressed in (FROL and purified. On the other hand, AGB1
RNA was synthesized, and translated using  35S-methionine. The product was added to
the matrix containing AGG1-GST and GST. Strong binding of AGB1 to AGG1-GST
fusion protein together with no binding to single GST reveals interaction of  and 
subunits (Mason and Botella, 2000).
 úOLQNHGHIIHFWRUV
   The  dimer activates a wide range of effector molecules inside the cell. These
molecules include some isomers of adenylyl cyclase, phospholipase C, phospholipase
A2, phosphoinositide 3-kinase and K+ channels.
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   Adenylyl cyclase is an intracellular enzyme that catalyzes the formation of cAMP
using Mg2+ bound ATP. Sharing a common domain of two membrane spanning regions
of six .-helices which connect 40-kDa cytoplasmic domains; nine different isofor ms of
adenylyl cyclases have been cloned and expressed to date, designated as AC I to IX. All
of the isoforms are subject to activation by G.s additionally, type I is inhibited while
type II and IV are activated by  subunits (Morris and Malbon, 1999). However, both
activation and inhibition requires high concentrations of  (Tang HWaO., 1992).
   Inositol lipid-specific PLCs consist of three groups ,  and /. Among these, the
four PLC-  isoenzymes are potential targets for G proteins and  dimer can activate
all of these isozymes. PLC- forms secondary messengers such as phosphaditylinositol
3-kinase (IP3) and diacylglycerol (DAG) by hydrolyzing inositol lipids, which
respectively, controls the intracellular levels of Ca2+ and protein kinase C (PKC), to
progress in cell growth and cell fate. For PLC-3, the .q and  subunits are equally
effective while for the other member of PLC- family, .q is 50 to 100 fold more
effective than . The lower capacity of  subunits when compared with the . subunits
may play role as a level of selectivity in receptor regulation of PLC- enzymes. Two
structurally conserved regions are observed in PLC- enzymes suitable for subtrate
binding and catalysis, named X and Y domains. Although the complete mechanism
between PLC- and G./G has not been defined structurally, The X and Y regions that
comprise the NH2 terminus, the inter X-Y region and the COOH terminus functions in
PLC- G protein coupling (Morris and Malbon, 1999).
   Phosphoinositide 3-kinases (PI 3-kinases) are a group of ATP-dependent
enzymes that catalyze the phosphorylation of three myositol containing phospholipids
phosphatidylinnositol, phosphatidylinositol 4-phosphate and PIP2 forming
phosphatidylinositol 3-phosphate, phosphatidylinositol 3,4-bisphosphate and
phosphatidylinositol 3,4,5-triphosphate, respectively. PI 3-kinases perform function in
many intracellular processes including receptor mediated signaling, protein trafficking
and mutagenesis. Many PI 3-kinases studied in mammalian cells are reported to be
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activated by G protein  subunits. Recently, p85 associated PI 3-kinase found in
human platelets is shown to be activated by  subunits (Carter and Downes, 1992).
   Phospholipase A2 (PLA2) which catalyzes the rate limiting step in the synthesis of
prostanoids, the release of arachidonic acid from plasma membrane lipids, are activated
by the G subunit in retina (Jelsema and Axelrod, 1987).
   K+ concentration and the pumping of K+ channels are important aspects of
contraction of heart muscles. Hyperpolarization leads to slowing in the contraction rate
of the heart. Different studies suggested that the K+ channel regulating the contraction
rate of heart is directed by G protein dependent mechanisms. Addition of G resulted in
up to 500 fold increase in channel activity (Kim HWDO., 1989; Wickman HWDO., 1994).
 3ODQW*3URWHLQ&ODVVLILFDWLRQ
Gene Species Classification Reference
*3$ Arabidopsis G Ma et al., 19907*$ Tomato G Ma et al., 1991
LjGPA1 Lotus G Poulsen et al., 1994
5*$' Rice G Ishikawa et al., 1995; Seo et
al., 19956*$ Soybean G Kim et al., 19956*$ Soybean G Gotor et al., 19961W*3  Tobacco G Saalbach et al., 19991W*$ Tobacco G Ando et al., 2000
/*3  Lupin G Kusnetsov and Oelmueller,
1996b$I*  Wild oat G Jones et al., 1998
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3*$3*$ Pea G Marsh and Kaufman, 1999
SOGA1 Spinach G Perroud et al., 2000
13*3$ 1LFRWLDQDSOXPEDJLQLIROLD G Kaydamov et al., 2000$*% Arabidopsis G Weiss et al., 1994=*% Maize G Weiss et al., 1994
TGB1 Tobacco G
Kusnetsov and Oelmueller,
1996a5*% Rice G Ishikawa et al., 1996$I*  Wild oat G Jones et al., 1998$I*  Wild oat Possible G Jones et al., 1998
13*3% 1LFRWLDQDSOXPEDJLQLIROLD G Kaydamov et al., 2000$** Arabidopsis G Mason and Botella, 2000$** Arabidopsis G Mason and Botella, 2001
*&5 Arabidopsis Potential heterotrimeric G
protein receptor
Josefsson and Rask, 1997;
Plakidou-Dymock et al.,
1998
0/2 Barley Potential heterotrimeric G
protein receptor
Devoto et al., 1999
$W;/* Arabidopsis Extra large GTP binding
protein
Lee and Assmann, 1999
3V'5* Pea Developmentally regulated
G protein
Devitt et al., 1999
$W'5* Arabidopsis Developmentally regulated
G protein
Etheridge et al., 1999; Devitt
et al., 1999
5'+ Arabidopsis (putative GTP-binding
protein)
Schiefelbein and Somerville,
1990$7*% Arabidopsis GTP-binding protein Biermann et al., 1996IZ25); Tomato (putative GTP-binding
protein)
Frary et al., 2000
Table 2.1 Plant G protein designations $VVPDQQ60
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 8QFRQYHQWLRQDO*73ELQGLQJSURWHLQVLQSODQWV
   In plants there are some other GTP binding proteins having yet unidentified
domains. Very large G proteins including AtXLG1, AtXLG-like and G.-putative can be
considered as the first group, among which only AtXLG1 gene is the characterized one.
Although AtXLG1 is shown to encode an instable protein in recombinant studies, it
possesses a helical and a C-terminal G.-like domain in addition to an Asp/Glu rich loop.
Another example of Arabidopsis large proteins can be RHD3, a 89 kDa protein
containing two regions common to GTPases, thougt to be effective in cell proliferation
in the shoot and root parts of the plant (Assmann, 2002). Two other G proteins, smaller
than the mentioned ones above are $ WKDOLDQD ATGB1 (Biermann HW DO., 1996) and
tomato ORFX (Frary HWDO., 2000).
 /LSLGPRGLILFDWLRQV
   Heterotrimeric G protein . and  subunits are subject to lipid modifications at
their specific regions. No G protein  subunit has been identified to contain lipid
modification yet. G. subunits are palmytoylated and/or myristoylated while G subunits
are isoprenylated by either farnesyl or geranylgeranyl addition (Houslay, 1991).
   All of the G protein . subunits cloned to date are shown to have specific binding
sites for palmitate or myristate, or both. Myristoylation, which is generally called N-
myristoylation occurs at the glycine (generally Gly-2) residue of the very N-terminus of
the alpha subunit, as a co-translational addition. Myristate is a 14-carbon  saturated fatty
acid. The amide bond, linking a myristate to glycine residue at the N-terminus is thougt
to be an irreversible binding and seen in .i family (i1, i2, i3, o, z, t) of the . subunits.
Specifically, .t subfamily in retinal photoreceptor cells contains three additional
hydrophobic fatty acylations, which could be an example of tissue specific differences,
resulting from different fatty acid pools of the cells. In addition to  N-myristoylation, all
G. subunits except the .t subfamily are palmitoylated at their cysteine residues in the N-
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terminus. Palmitate is a 16-carbon saturated fatty acid and binding is thougt to be
reversible (Wedegaertner HW DO., 1995).  Recently, a second palmitoylation at glycine
residue, in the N-terminus adjacent to the palmitoylated Cys, has been identified by
Kleuss and Krause by peptide mass fingerprinting. The lipid modification hence occurs
in G. subunits as both myristoylation and palmitoylation most of the time and the
sequence M-G-C is studied to represent the signal for both acylations (Sprang, 1997;
Wedegaertner HWDO., 1995).
   Lipid modifications provide essential activities for the alpha subunits.
Myristoylation and palmitoylation results in the membrane anchoring of .. Palmitate,
containing a 2-C more tail region than myristate resulting in a greater hydrophobicity,
confers a stronger association with membrane phospholipids (Wedegaertner HW DO.,
1995). Myrsitate, probably is not sufficient for a protein membrane linkage and requires
the involvement of positive charges and other protein-protein interactions while
palmitate has an adequate binding energy to anchor the alpha subunit to the membrane
(Peitzsch HW DO., 1993). Fatty-acylated . subunits also have higher affinity protein-
protein interactions fro the other G protein subunits. Thioacylation (palmitoylation at
the Cys residue) increases the effective linkage of Gs. to G to five-fold, together with
inhibiting the interaction of it with the G protein regulators (Manahan HWDO., 2000).
   Heterotrimerc G protein  subunits are isoprenylated by the addition of either a
15-carbon isoprenoid farnesyl (only in the case of 1 specific to retina) or a 20-carbon
isoprenoid geranygeranyl. The addition occurs to the Cys residue of the CAAX box,
which is common in all  subunits. After isoprenylation, three aminoacids falling to the
C-terminal site of modified point are removed and the new C-terminus is
carboxymethylated (Wedegaertner HWDO., 1995).
   As in the case of . subunits, the lipid modifications in  subunits help membrane
anchoring and play role in protein-protein interactions. The farnesyl group added to the subunit may interact directly with an integral membrane protein, or a transmembrane
receptor. Geranygeranyl group, with a longer hydrophobic tail, is more eligible for that
function, than farnesyl (Manahan HWDO., 2000). Expression of mutant, non-prenylated 
subunits in cultured cells resulted in  dimers located in cytosolic rather than
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membrane fractions (Simonds, 1994). The yeast G subunit Ste18p is shown to be
farnesylated on its C-terminal Cys group. In the absence of prenylation the protein is
nonfunctional. However, replacement of the C-terminal lipidation region with a
transmembrane domain results in a functional protein, which argues with the membrane
anchoring funtion of lipid modification. Indeed, isoprenylation is considered to have a
minor effect, if any, on the membrane localization of gamma subunits, when compared
with the interaction of coiled region of gamma with membrane phospholipids.
Additionally, carboxymethylation also contributes to the membrane association of the dimer, by neutralizing the negatively charged C-terminus of   (Wedegaertner HWDO.,
1995). It is stated by Silvius and lHeureux that isoprenylation of  isrequired for
appropriate interaction of  dimer with the . subunit but the structural aspect is not
well understood.
Figure 2.7 Lipid modifications of G protein . and  subunits (Assmann, 2002)
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 0$7(5,$/6$1'0(7+2'6
 0DWHULDOV
 &RPPHUFLDO.LWV
PCR Core System II (Promega)
pGEM® -T and pGEM® -T Easy Vector Systems (Promega)
Quiaquick® PCR Purification Kit (250) (QIAGEN
Quiaquick® Gel extraction Kit (250) (QIAGEN)
Quiaprep® Spin Miniprep Kit (250) (QIAGEN)
QUIAGEN® Plasmid Midi Kit (100) (QIAGEN)
TOPO® XL PCR Cloning Kit (Invitrogen)
TOPO® TA Cloning Kit (Invitrogen)
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TOPO® T7 Expression System (Invitrogen)
TOPO® pTricHis Expression System (Invitrogen)
 &KHPLFDOV
All chemicals were supplied by Fluka (Switzerland), Merck (Germany), Riedel de Häen
(Germany), and SIGMA (USA).
 9HFWRUV
AGG1-pBS was kindly donated by Dr. Botella (Universtiy of Queensland, Australia)
pUC18 (Fermentas)
pGEM® -T Easy (Promega)
pGEX-4T2 (Amersham Pharmacia Biotech)
pGFPuv (Clontech)
pCR® II- TOPO® (Invitrogen)
TOPO-T7 (Invitrogen)
TOPO-pTricHis (Invitrogen)
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 &HOOV
Different (FROL strains containing TOP10, XL1Blue, BL21 (DE3), BL21(DE3)pLysE,
Rosetta(DE3), Rosetta(DE3)pLysS were kindly provided by EMBL, Hamburg
BL21-CodonPlus® (DE3)-RIL Competent Cells (Strategene)
TOP10 F (Invitrogen)
BL21 (DE3) pLysS (Invitrogen)
 (Q]\PHV
 5HVWULFWLRQ(Q]\PHV
5( &XWWLQJ6LWH
%DP+O G GATCC
(FR5, G AATTC
+LQG,,, A AGCTT
6DF, GAGCT C
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;KR, C TCGAG
6SHO A CTAGT
+LQF,, GT(T/C)(A/G)AC
.SQ, GGTAC C
1FR, C CATGG
1GHO CA TATG
1KH, G CTAGC
 '1$3RO\PHUDVHV
Tag Polymerase(Promega)
DNA Polymerase I Klenow fragment for Fill-in (Promega)
 &DOI,QWHVWLQH$ONDOLQH3KRVSKDWDVHIRU¶GHSKRVSKRU\ODWLRQ3URPHJD
 /LJDVH
T4 DNA Ligase (Fermentas)
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LigaFastTM Rapid Ligation System (Promega)
 3ULPHUV
Primers were designed according to the coding sequence of $**www.arabidopsis.org) Primers with restriction enzyme sites were purchased from
SEQLAB (Germany) and SIGMA (USA).
 %XIIHUVDQG6ROXWLRQV
Standard buffers and solutions used in cloning and electrophoresis were prepared
according to Sambrook J., 2001.
 (TXLSPHQW
All equipment used in this study can be found at Appendix D.
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 0HWKRGV
 %DFWHULDO&HOO&XOWXUHV
   Bacteria were grown for 10-18 hours in LB liquid medium with or without
selective reagents prior to application depending on cell type and plasmid copy number.
All incubations were performed at 37ºC, with 300 rpm shaking. Millers LB Agar solid
medium was used containing selective reagents for the growth of bacteria after
transformation protocols.
   Glycerol banks of cells were prepared as %85/ %15 in liquid culture/glycerol
ratio.
   Competent cells used for transformation were prepared according to  Sambrook J,
2001.
 3&53RO\PHUDVH&KDLQ5HDFWLRQ
PBS-AGG1 vector taken from Dr. Botella was used for all PCR protocols. Annealing
temperatures of primers with and without restriction sites were estimated according to
the formula in the PCR Core System II (Promega). The following PCR conditions were
followed in all amplification processes:
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94°C à 1 min
94°C à 1 min
55°C à 3 min 25 cycles
72°C à 1 min
72°C à 5 min
4°C   à Hold
 3XULILFDWLRQRI3&5SURGXFW
   PCR product was purified either from the 1% Agarose gel with Quiaquick® Gel
extraction Kit (250) (QIAGEN) or directly with Quiaquick® PCR Purification Kit (250)
(QIAGEN).
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 $JDURVH*HO(OHFWURSKRUHVLV
   Plasmid isolation, restriction digestion analysis of samples on 1% Agarose at
105mV constant voltage for 50 min. Samples to be extracted from gel were run on 1.5%
Agarose at 105mV constant voltage for 50 min.
 6'63RO\DFU\ODPLGH*HO(OHFWURSKRUHVLV
   Proteins to be observed on polyacrylamide were mixed with 5X loading buffer
and 5% 2-Mercaptoethanol and denaturated at 95°C for 2.5 min. Polyacrylamide gels
were prepared in the following ratios:
5% Stacking Gel 15% Seperating Gel
50 mM Tris-HCl pH 6.8 375 mM Tris-HCl pH 8.9
5% Acryl-bisacryl (30%-0.8%) 15% Acryl-bisacryl (30%-0.8%)
0.04% 20 % SDS 0.1% 20 % SDS
0.075% 10 % APS 0.075% 10 % APS
0.05% TEMED 0.05% TEMED
The gels were stained with Comassie staining.
 3ODVPLG,VRODWLRQ
   Purified plasmids containing were digested with appropriate restriction enzymes
according suppliers instructions to verify the presence of GPA1. (Enzyme/reaction mix)
v/v ratio was kept at 1/10 or smaller in all digestions.
32
 5HVWULFWLRQ(QGRQXFOHDVH'LJHVWLRQ
   Purified plasmids containing insert were digested with appropriate restriction
enzymes according suppliers instructions to verify the presence of GPA1.
(Enzyme/reaction mix) v/v ratio was kept at 1/10 or smaller in all digestions.
 /LJDWLRQ
   Isolated  pGEX4T-2  was ligated with $** containing the same restriction site
with the vector, with different insert:vector ratios. PCR amplified $** with restriction
sites was ligated to pUC18 digested with those restriction sites, and directly to
pGEMTEasy vector. PCR amplified $** with no restriciton sites was ligated directly
to TOPO-T7, TOPO pTrcHis expression vectors and pCR II- TOPO subcloning vector.
The reaction mixtures were incubated 5 min. at room temperature.
 7UDQVIRUPDWLRQ
   Ligation mixtures were transferred into different endonuclease deficient strains of( FROL- XL1 Blue, TOP10, BL21 (DE3) and BL21 (DE3) pLysS. Transformed cells
were plated on appropriate antibiotic selective LB plates prepared according to the
ligation vectors.
 &RORQ\6HOHFWLRQ
   Positive colonies were selected and grown on liquid LB culture containing
appropriate antibiotic selection for both preparing glycerol stocks and plasmid isolation.
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 6HTXHQFH9HULILFDWLRQ
   QIAGEN® Plasmid Midi Kit (100) (QIAGEN) purified plasmids containing$** were sent for sequence analysis.
 3URFHGXUHVXVHGLQVXEFORQLQJ
 6XEFORQLQJRI$** XVLQJS8&
$** was PCR amplified from AGG1-pBS plasmid using SacI restriction site in
the forward primer and EcoRI restriction site in the reverse primer. Commercial pUC18
vector was digested in the following conditions:
Volume (L)
10X Tango Buffer 2
pUC18 5
HincII 1
ddWater                                12
Total 20
   PCR purified $** was subjected to fill-in reaction using DNA polymerase
Klenow fragment and digested pUC18 was dephosphorylated. These two samples,
without extracting from the gel, were directly ligated in 10:1 insert:vector ratio (v/v).
Tranformation protocol into TOP10 competent cells was followed according to
Maniatis HWDOand 10 colonies were picked that 2 of them were verified by restriction
digestion to contain the insert, one is in forward; the other is in reverse direction.
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 6XEFORQLQJRI$** XVLQJS*(07(DV\
   PCR amplified $** having SacI and EcoRI restriction sites was ligated with
pGEMTEasy vector in a 3:1 insert:vector ratio. Transformation of TOP10 competent
cells was followed by verification of the presence of insert by restriction endonuclease
digestion.
 3URFHGXUHVXVHGLQH[SUHVVLRQFORQLQJ
 &ORQLQJRI$** XVLQJ72327H[SUHVVLRQYHFWRU
   PCR amplified $** is ligated with TOPO-T7 expression vector and transferred
into (FROL BL21 (DE3) pLysS competent cells. The presence and direction of insert is
verified by PCR and polyacrylamide gel electrophoresis.
 &ORQLQJRI$** XVLQJ7232S7UF+LVH[SUHVVLRQYHFWRU
   PCR amplified $** is ligated with TOPO-pTrcHis expression vector and
transferred into (FROL BL21 (DE3) pLysS competent cells. The presence and direction
of insert is verified by PCR and polyacrylamide gel electrophoresis.
 &ORQLQJRI$** XVLQJS*(;7H[SUHVVLRQYHFWRU
   Both TOPO-AGG1 and pGEX4T-2 were digested with EcoRI and XhoI in the
following conditions.
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   Volume (L)
DNA 5
EcoRI 1
XhoI 1
10X Tango Buffer 4
ddWater 9
Total 20
   The digested vectors were ligated in 1:1 insert vector ratio (w/w) and transferred
into ( FROL BL21(DE3) competent cells and the presence of insert was verified by
restriction digestion.
 ([SUHVVLRQ
   The expression cells containing $**+vector were subcultured with 5 ml
LB+ampicillin and the day after diluted to 0.02 OD. Cultures were induced with 0.8
mM IPTG near O.D=1 and samples were taken at 2 hour intervals for 8 hours. The
pellets were lysed, sonicated and run on 5-15% SDS-polyacrylamide gel.
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 :HVWHUQ%ORWWLQJ
   5-20% SDS-polyacrylamide gel was blotted on PVDF membrane at 25
mAconstant current for 3 hours. Blotted membrane was stained with Poncaeu S stain fro
15 min and washed with PBS. PVDF memnbrane was blocked with blocking solution
containing 0.2% Tween and 5% non-fat milk powder, incubated with anti-His antibody
for 2 hours and transferred to secondary antibody (HSP) solution where it was incubated
for 2 hours. The membrane was applied with Pharmacia Chemiluminescent detection
solution and resulting bands were identified using Pharmacia ECL+ X-ray film.
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 5(68/76
 S%6$**DQGS%6$**SODVPLGV
   The AGG1-pBS plasmid was kindly provided by Dr. Botella as blotted on paper.
DNA was transferred into solution by cutting the blotted spot and  with vigorous
shaking in TE buffer. As can be seen in figure 4.1, AGG1-pBS  and AGG2-pBS were
visualized on 1% Agarose gel before further manipulation:
Figure 4.1 Agarose gel electrophoresis of AGG1-pBS and AGG2-pBS plasmids
   According to the plasmid map supplied by Dr. Botella, $** fragment had been
inserted between Kpn I and Spe I restricton enzyme sites and could be excised by these
enzymes to appear as a ~ 420-base fragment , as shown in figure 4.2 on 1% Agarose
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gel. A 297 bp region of this fragment was expected to correspond to $**. The actual
verification of $** was carried out by sequencing. A 700 bp sequenced region of
AGG1-pBS vector is given in Appendix C and $** sequence is between nucleotides
71 and 367 in this sequence.
Figure 4.2 Agarose gel electrophoresis verifying the presence of $** in AGG1-pBS
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 6XEFORQLQJDQG6HTXHQFHYHULILFDWLRQRI$**
 ,QVHUWLRQLQWRS8&
 3&5DPSOLILFDWLRQRI$**
   $** was amplified using the following primers. Sac I restriction site is present
in Forward primer and EcoRI restriction site is present in Reverse primer. These
restriction sites are underlined.
Forward primer: 5- TATATAGAGCTCATGCGAGAGGAAA- 3 and
Reverse primer: 5  GCGGCGGAATTCTCAAAGTATTAAG- 3
   A 6 bp additional sequence was used in primers before the restriction sites. This
additional sequence is different in the forward and reverse primers, to equalize the
annealing temperatures, making use of different bond strengths of A-T and G-C pairs.
   All PCR amplifications, both for cloning and subcloning were performed using
the AGG1-pBS vector as template. PCR amplification using the above primers were
used for also subcloning into pGEMTEasy vector. Results of amplification of $**
were monitored by agarose gel electrophoresis. As can be seen on figure 4.3 a fragment
of about 300 bp length was obtained as the PCR product
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Figure 4.3 PCR amplification of $**
 /LJDWLRQLQWRS8&
   To prepare a pUC18-AGG1 construct for using as a subcloning vector in order to
make a GFP-AGG1 fusion protein, the amplified $** was tried to be ligated into
pUC18. PCR amplified $** was gel purified and the flanking regions were filled with
DNA Polymerase Klenow fragment, resulting in blunt ends. The commercial pUC18
was also cut with the same enzyme and the two mixtures were ligated directly, without
gel purification(FROL TOP10 cells were transformed with potential construct and 10
colonies were selected according to blue-white colony screening using ampicillin
resistance as selective agent. Plasmids isolated from liquid cultures of these cells are
shown in figure 4.4. pUC18 plasmid normally have SacI and EcoRI Restriction sites in
its MCS. Digestion of the possible construct using SacI will result in a band of ~325 bp
if it is inserted in the forward direction, the same band will be observed using EcoRI if
it is inserted in the reverse direction. Restriction digestion of these plasmids using SacI
and EcoRI, separately, resulted in 2 inserts: one in the forward direction (named A1)
and one in the reverse direction (named A9), on 1% Agarose gel, which is shown in
figure 4.5. Subsequently clones A1 and A9 were sequenced verifying the presence of$** in the pUC18 vector.
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Figure 4.4 Isolated possible constructs
Figure 4.5 Verification of $** in pUC18 by Agarose gel electrophoresis using SacI
and EcoRI restriction enzymes.
 ,QVHUWLRQLQWRS*(07(DV\
   PCR amplified $** was gel purified, inserted into pGEM T-Easy vector and
TOP10 cells were transformed with the construct. 10 $** positive colonies were
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selected according to blue-white colony screening using ampicillin resistance. Plasmids
were isolated from these cells in liquid cultures. . pGEM T-Easy vector facilitates A-
tailing ligation of the fragment between two flanking Eco RI sites and presence of the
insert can be verified by digestion of the isolated plasmids with Eco RI. The restriction
digestion result on 1% Agarose gel is shown in figure 4.6. One plasmid (named B2) was
verified by sequencing.
Figure 4.6 Verification of $** in pGEMTEasy by Agarose gel electrophoresis
using SacI and EcoRI restriction enzymes. Lane 1: Marker bands corresponding to 500,
400, 300, 200, 150 bps respectively. Lanes 3-6: $**
 ,QVHUWLRQLQWRS&5,,7232
   AGG1+PCR-TOPOII construct was prepared as a first step in constructing
AGG1-pGEX4T-2 vector. Hence, primers were designed in order to insert $** in-
frame into pGEX4T-2. $** was amplified from AGG1-pBS using the following
primers. The forward primer contains EcoRI Restriction site while the reverse primer
contains XhoI Restriction site. These Restriction sites are underlined below:
Forward primer: 5- GAATTCCATGCGAGAGGAAACTGTGGTTTAC- 3 and
Reverse primer: 5  CTCGAGTCAAAGTATTAAGCATCTGCAGCC- 3
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Figure 4.7 PCR amplification of $** from AGG1-pBS fro insertion into pCRII-
TOPO plasmid.
Figure 4.8 Plasmid isolation of possible AGG1-pCRII-TOPO constructs.
   Gel purified PCR product was directly ligated with PCR-TOPO subcloning vector
and transferred into TOP10F competent cells. 2 light blue colonies were picked and
one of them was verified to contain $** by restriction digestion using EcoRI + XhoI,
on 1% Agarose gel.
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Figure 4.9 Restriction digestion using EcoRI+XhoI. One of the possible constructs did
not contain $** (#1) while the other did (#2).
 &ORQLQJRI$** XVLQJH[SUHVVLRQYHFWRUV
 ,QVHUWLRQLQWR723217DQG7232S7UF+LV
   TOPO-NT7 and TOPO-pTrcHis are two commercial expression vectors
(Invitrogen) for directly inserting PCR products. As shown in the vector maps in
Appendix A, ligation is achieved by making use of two Adenine bases added during
PCR, complemented with the action of Topoisomerase. Since subcloning procedure is
bypassed and the gene is directly inserted into the expression vectors. Primers
containing no restriction sites were designed and used. $** was PCR amplified using
the below primers. Two same samples were observed preparatively on 1% Agarose gel,
which were then added to each other, for getting rid of overloading.
Forward primer: 5- ATGCGAGAGGAAACTGTGGTTTAC- 3 and
Reverse primer: 5  TCAAAGTATTAAGCATCTGCAGCC- 3
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Figure 4.10 PCR amplification of $** from AGG1 pBS plasmid for insertion into
TOPO expression vectors. Lanes 3 and 4 (C1 and C2) are control reactions of PCR.
   Gel purified $** was directly ligated with different amounts of TOPO-NT7 and
TOPO-pTrcHis expression vectors. TOP10F competent cells were transformed with
potential constructs and presence and direction of inserts were checked by restriction
endonuclease digestion. The vectors contain useful Restriction sites at sites of insertion,
as shown in Appendix A. For NT7, the presence of insert was verified by using NdeI +
HindIII. For pTrcHis, the presence of insert was verified by using BamHI+EcoRI.
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Figure 4.11 Agarose gel electrophoresis verifying the presence of $** in TOPO
expression vectors. Lanes 2-7 (10-15) include isolated possible AGG1-TOPONT7
constructs digested with NdeI+HindIII. Lanes 8-10 (3-0, 3-1, 3-2) include isolated
possible AGG1-TOPOpTrcHis constructs digested with BamHI+EcoRI.
   The verification of insertion direction was done by PCR. A combination of
Forward primer used for PCR amplification of $** and Reverse primer supplemented
with the vector kits were used. With this combination, if a band around 300 bp is
observed, the direction would be correct. $** forward primer and TOPO reverse
primer was used and the direction of the inserts were determined. 1% Agarose gel
Electrophoresis is showing that insertion is achieved in the correct direction.
Figure 4.12 Verification of the direction of inserts by PCR using $** forward primer
and TOPO reverse primer. Result shows that all are insert are in forward direction.
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 ,QVHUWLRQLQWRS*(;7
   AGG1-TOPO construct was digested with EcoRI and XhoI restriction enzymes,
and extracted from 1.5% Agarose gel. PGEX4T-2 plasmid, isolated from (FROL BL21
series was also digested with the same same ezymes and ligated with $**. The
construct was transferred into both XL1Blue and BL21 competent cells. The presence
of the insert was verified by restriction digestion, observed on 1% Agarose gel.
Figure 4.13 Agarose gel elctrophoresis showing the presence of $** in pGEX4T-2
plasmid.(Lane1: Fermentas Mass Ruler Low Range Molecular Weight Marker)
 ([SUHVVLRQ
 ,QGXFWLRQRI%/'(FHOOVFRQWDLQLQJ723217$**
   (FROL BL21 (DE3) cells carrying TOPONT7-AGG1 were induced using 0.8mM
and 1.25mM IPTG for  8 hours and appropriate amounts of samples were taken at 2-
hour intervals. 10 uL samples were loaded on 5-15% SDS-polyacrylamide gel. As seen
from the gel photos, no expression of $** were observed, when compared with the
empty BL21 (named B) and non-induced cells (named -).
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,QLWLDO W  W K W K W K W K W RQ%/'( 0.22 0.75 2.58 3.4 3.9 4.19 10
 0.3 0.93 2 3.21 3.01 3.3 2.7
P0 0.31 1.04 2.35 2.78 2.98 3.16 9.42
P0 0.31 1.04 2.34 2.76 2.79 2.9 2.11
Table 4.1 OD measurements of cultures taken at 2 hour intervals. (+) cells are induced
at t=0
Figure 4.14 SDS-polyacrylamide gel electrophoresis of samples taken from cells at
above specified time points. (Solubilized samples)
Lane # Sample Lane # sample
1 Molecular Weght Marker 6 BL21 (DE3) at t=1
2 BL21 (DE3) at t=0 7 13 (+0.8mM IPTG) at t=1
3 13 (-) at t=0 8 13 (+1.25mM IPTG) at t=1
4 13 (+) at t=0 9 BL21 (DE3) at t=2
5 BL21 (DE3) at t=1 10 13 (+0.8mM IPTG) at t=2
11 Molecular Weght Marker 16 13 (+0.8mM IPTG) at t=3
12 13 (-) at t=2 17 13 (+1.25mM IPTG) at t=3
13 13 (+1.25mM IPTG) at t=2 18 BL21 (DE3) at t=4
14 BL21 (DE3) at t=3 19 13 (-) at t=4
15 13 (-) at t=3 20 13 (+0.8mM IPTG) at t=4
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Table 4.2 Sample description for Figure 4.13
Figure 4.15 SDS-polyacrylamide gel electrophoresis of samples taken from cells at
above specified time points. (pellet samples). Lane 2: t=0, Lanes 3-5: t=2, Lanes 6-8:
t=3, Lanes 9-10: t=4
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Figure 4.14 (continued): Lanes 2-3: t=4, Lanes 4-7: t=5
 ,QGXFWLRQRI%/FHOOVFRQWDLQLQJ7232S7UF+LV$**FRQVWUXFW
   ( FROL BL21 (DE3) cells carrying TOPOpTrcHis-AGG1 were induced with
0.8mM IPTG for 6 hours and appropriate amounts of samples were taken at 2-hour
intervals.
,QLWLDO W  W K W K W K%/'( 0.25 1.16 2.31 2.84 3.18
&RQWURO 0.8 0.91 2.17 2.74 3.27
 0.12 0.68 1.73 2.36 2.17
 0.08 0.72 1.03 0.81 0.284
Table 4.3 OD measurements of cultures taken at 2 hour intervals. (+) cells are induced
at t=0
   10 pL samples were loaded on 5-15% SDS-polyacrylamide gel. As seen from the
gel photos, no expression of $** were observed, when compared with the empty
BL21 (labeled B) and non-induced cells (labelled -). C denotes pTrcHis expression
control.
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Figure 4.16 SDS-polyacrylamide gel electrophoresis of samples taken from cells at above
specified time points. Lane 1: Molecular Weight Marker (Fermentas), Lanes 2-5: t=0,
Lanes 6-9: t=1, Lane10: Molecular Weight Marker (Fermentas), Lanes 12-15: t=2, Lanes
16-19: t=3
   Large scale (200 ml.) ( FROL BL21 (DE3) cells carrying TOPOpTrcHis-AGG1
were induced with 1 mM IPTG for 4 hours. According to the assumption that the
protein is toxic to (FROL strain, cells are induced at a relatively high concentration (near
O.D=1.5) and samples were taken at smaller time intervals. Sampling has continued
until possible toxicity has decreased cell concentraion (O.D= 1.93).
,QLWLDO W  W PLQ W PLQ W PLQ W PLQ%/'( 1.13 2.36 2.89 3.54 3.93 5.7
 0.63 1.77 2.23 2.71 2.82 5.11
 0.68 1.66 1.68 1.99 2.39 1.93
Table 4.4 O.D. measurements taken at specified time points. (+) cells are induced at t=0
Figure 4.17 SDS-polyacrylamide gel electrophoresis of samples taken from cells at
above specified time points
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Lane # sample Lane # sample
1 Molecular Weght Marker 6 3-2 (-) at t=2
2 BL21 (DE3) at t=0 7 3-2 (+) at t=2
3 3-2 (-) at t=0 8 3-2 (-) at t=4
4 3-2 (+) at t=0 9 3-2 (+) at t=4
5 BL21 (DE3) at t=2 10
Table 4.5 Sample description of Figure 4.16
The induced cultures were speculated to synhesize maximum number of protein at t=2,
so t=2 sample was used for Western blot analysis. For the verification of correct
localization of bands on PVDF membrane, the SDS gel was loaded with the samples
twice. One half was comassie stained and the other half was blotted onto membrane. In
addition, a second protein known to contain His-tag was used as the control of the
study. The localization of the two bands on membrane matches correctly to the ones on
SDS gel as shown in Figure 4.18, hence the two bands on the membrane are
pETM_GFP_Imm (control) and AGG1, respectively.
Figure 4.18 5-20% SDS-PAGE comassie stained and correspondent Western Blot
analysis of samples taken from induced cells at t=2. Left: Lane 1: t=2 induced cells,
Lane 2: Protein MW marker (bands corresponding to 35, 25, 18.4, 14.4 kDa from top to
bottom) Lane 3: pETM_GFP_Imm protein containing His tag. Right: Western Blot of
left gel. Lane 1: pETM_GFP_Imm, Lane 3: AGG1
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 ',6&866,21
   The main and long-term aim of the study is to solve the structure of plant G
protein -subunit using X-ray crystallography and study the interactions of the subunits
in the plant heterotrimer ( if such a functional entity exists) using small angle X-ray
scattering. This requires the cloning and high-yield expression of the gene in an optimal
host strain and efficient purification of the resulting protein. $** gene, provided
initially in pBS vector has been inserted into 3 subcloning and 3 expression vectors and
3 of them (AGG1-pUC18, AGG1-pGEMTEasy, AGG1-TOPOpTrcHis) have been
shown to be cloned in frame and without mutation. Expression of  AGG1 protein in (&ROL host strains has been demonstrated by western blot analysis.
AGG1-pBS
AGG1
Subcloning
vectors
Expression
vectors
PGEMT
Easy
pCRTOPO pGEX4T-2 TOPO-
NT7
TOPO-
pTrcHis
pUC18
AGG1
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  
   Working with AGG1 has had special challenges due to its low molecular weight
protein, only 7 kD, it existing in a tight complex with G-beta in ammalian and other
systems where it has been identified and due to possible complications in stablising the
3D fold of this small protein in an prokaryotic system.
 &ORQLQJ
AGG1-pBS plasmid, which was kindly provided by Dr. Botella (University of
Quennsland, Australia) was firstly sequenced to verify the location and the sequence of
the gene. This proved to be justified since the other construct named as AGG2-pBS by
Dr. Botella was shown not to contain $** gene correctly after two sequencing
attempts carried out by different sequencing companies.
   During early stages of the project attempts were made to insert $** gene into
pUC18 subcloning vector and then to transfer it to the pGFPuv vector for expression as
a fusion protein together with GFP. For this purpose, a forward primer containing SacI
restriction site and a reverse primer containing EcoRI restriction site were designed.
These would allow cloning of $** in the 3 MCS (Multiple Cloning Site) of pGFPuv,
excising hence bypassing- the stop codon of GFP gene, without interfering with the
chromophore region. The stop codon of $** would therefore be used as the stop
codon of GFP-AGG1 fusion protein. However, several attempts failed to produce the
pGFPuv+AGG1 construct (data not shown in results section). As can be seen from the
vector map of pGFPuv in Appendix A, SacI and EcoRI restriction sites are very close to
each other (~10 bases). This can inhibit the correct fitting of two different enzymes to
their targets because of competing for nearly the same region on DNA. The inhibition of
binding probably resulted in failure of expected sticky ends because the excision of
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$** from pUC18 vector using the same restriction enzymes was succesful in every
trial.
The subcloning of $** into pUC18 was carried out in an unusual way. Instead
of gel extraction of digested vector followed by ligation, the HincII cut pUC18 was left
in tube and ligated with PCR amplified $** subjected to fill-in reaction directly. This
resulted in a combination of false positive transformants containing self-ligated pUC18
and as well as those containing AGG1-pUC18 construct, verified by restriction
digestion. A blunt-end ligation, which failed several times in other studies, was
achieved.
pCRII-TOPO vector making use of the topoisomerase enzyme was used for
subcloning. The resulting construct was digested with EcoRI and and XhoI, which were
the sites coming from previously designed primers in order to insert $** into
pGEX4T-2 plasmid. The AGG1-pGEX4T2 construct was succesfully prepared but
sequencing result showed an A to C single base mutation at the start codon of $**,
which can be due to either wrong synthesis (not design) of primer, wrong base pairing
in PCR or UV light exposure during the extraction from Agarose gel for purification.
 ([SUHVVLRQ
   Construction of fusion proteins is a convenient way of expressing genes in
organisms other than their natural origins. Every organism beginning from bacteria to
the ones having large genomes developed defense mechanisms to -unwanted-
molecules. Protection for the recombinant protein can be achieved using a fusion
partner for the gene of interest, especially for the small ones, to lessen the effect of the
defense mechanisms inside the host. Among these partners GFP would be a good choice
with its stable 3-D structure coming from a central chromophore region covered with a
beta-barrel composed of eleven beta strands at the sides and distorted alpha helices at
both ends (Philips, G.N.Jr., 1997). GST, a ~30 kDa less stable protein, is another
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candidate. In this study, GFP fusion could not be achieved and GST fusion protein
failed to be expressed due to the above mentioned point mutation.
   One of the cloned TOPO direct expression vectors was sequenced and did not
contain $** gene correctly. The other, being pCRTOPO-pTrcHis, was verified by
sequencing to contain $** in-frame. ( FROL BL21 (DE3) pLysS strains were
transformed with construct and induced with 0.8, 0.9, 1, 1.25 mM IPTG (only 0.9 and
1mM concentrations shown in results section). In all experiments, optical density of the
construct carrying cells showed a relatively low increase compared to the empty cells
and the cells carrying a control plasmid. In addition, the induced cultures usually did not
grow when they were left overnight. These results suggest potential toxicity of $** in
the host strains.
   Based on the assumption that the gamma subunit is toxic to transformed strains,
induction of cells at higher cell density has been tried. Any toxic protein will be fatal for
the cell if it is allowed to accumulate up to a certain concentration. So, if the number of
cells are incresead, it will possible to collect/detect the protein at low accumulated
amount at an early stage of synthesis before it reaches the fatal concentration in each
cell. Therefore, liquid cultures were grown until they reach O:D ~ 1.5 and then induced
with IPTG while in other experiments induction is done normally at 0.5-1 O.D.
Moreover, (. FROL (DE3)pLysS strains were selected for expressing a comperatively
lower  amount of T7 RNA polymerase for expression of toxic genes. pLysS does not
effect the growth rate of host while increasing the stability of expression plasmid. 
   As mentioned at the beginning, there are particular difficulties in cloning G
protein gamma subunit in bacterial systems compared to an ordinary cloning study.
First, the protein is very small (about 7-10 kDa) and 3-D structure of its mammalian
counterparts does not seem to be stable. As can be seen in figure 5.1, the two helical
domains are free to rotate and very accessible to external effects.
   This implies that the recombinant protein would be open to protease attacks in the
host cell. It is known that bacterial systems contain mainly serine proteases and PMSF
(phenyl- methyl sulfonyl fluoride) inhibits the activity of those proteases which was
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used in all experiments. In the last trial of expression studies, a protein inhibitor cocktail
purchased from Roche Chemicals (Complete) was used which blocks all serine and
metalloproteases.
Figure 5.1 Heterotrimeric Complex Of A Gt- /Gi- Chimera and The Gt- - Subunits.
Gamma subunit is shown in red.
   Second, G protein gamma subunit is normally found in cells complexed with the
beta subunit and it is impossible to separate the two subunits except for highly
denaturing conditions. No intracellular effector molecule has been reported to be bound
solely by the gamma subunit. Expression only of the gamma subunit gene will
definitely change the usual folding pattern of the resulting protein which can effect level
of synthesis. Because this is not a functional study, this is not that important but for X-
ray experiments, deduced structure of the gamma subunit should be compared with the
structure of beta-gamma dimmer.
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   Third, G protein gamma subunits found in eucaryotic organisms are subject to
post-translational modifications occurring as lipid modifications which maintains both
membrane anchoring and correct  binding. These modifications are absent in
prokaryotes which might lead to folding problems resulting in degradation.
   In spite of these difficulties concerning expressing such a protein having
eucaryotic origin, in a prokaryotic system, a combination of a number of approaches
resulted in the detection of protein synthesis. Large scale culture preparation, efficient
inhibiton of proteases, induction at high cell concentration are some these approaches.
In addition, $** is very difficult to detect by SDS-polyacrylamide gel electrophosis
because it is very small. It could not be detected in several SDS-PAGE experiments
possibly due to diffusing out of the gel. In the last trial, samples taken from induced
cultures were run on a 5-20% denaturing gel and blotted on PVDF membrane. Western
blotting resulted in the detection of His-tagged $**, which was verified by using
another His-tagged protein as control.
   Now that the G protein gamma subunit gene has been synthesized in a prokaryotic
system, the optimization of recombinant protein in terms of stability and quantity should
be performed. A more stable fusion protein involving AGG1 may be constructed trying
GST and GFP fusions again. In addition, because the natural partner of AGG1 is the
beta subunit, the dimer can be co-expressed by forming a beta-gamma construct. It is
also known that GST gene is high highly expressed and GST protein is synthesized in
high levels in the prokaryotic strains used. This can result in adequate quantity of AGG1
production for structural studies if an AGG1-GST fusion is constructed.
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 &21&/86,21
   Cell behavior is regulated by a complex network of intracellular and extracellular
signal transduction pathways. Guanine Nucleotide Binding Proteins (G proteins) are
intermediate molecules in this network whose structure and function should be well
characterized for understanding the whole mechanism.
   Structural studies require high amount pure proteins. Both in academic studies and
requirements in industry, deplete of natural resources lead to inevitability of genetic
engineering, by production of useful proteins in host organisms having very short life
spans. In this study $ WKDOLDQD G protein gamma subunit gene was cloned and
expressed in prokaryotic systems, for future structural studies.
   The selected organism was forced to express the gene and synthesize AGG1.
However, due to possible toxicity of the gene and degradation of protein due to several
reasons, synthesis level is low and may not be adequate for structural studies. Therefore,
both construction of more stable fusion proteins of AGG1 should be carried out and
expression studies should be done in other host organisms, including different strains of(FROL and  different prokaryotic systems as well as  insect cells and yeast.
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$33(1',;$
$F'1$VHTXHQFHRI$**IURP7$,5KRPHSDJH
ATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGC
GGGGGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTC
GCTTTCTTGGAGAAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCA
ACCGTGTGTGAGGAGCTGCTATCTGTCATCGAGAAAGGACCCGATCCTCTGT
TGCCACTAACCAATGGACCTTTGAACTTAGGATGGGACCGGTGGTTTGAAG
GACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGA
$$PLQRDFLGVHTXHQFHRI$**IURP7$,5 KRPHSDJH
MREETVVYEQEESVSHGGGKHRILAELARVEQEVAFLEKELKEVENTDIVSTVCEELLSVIEKGPDPLLPLTN
GPLNLGWDRWFEGPNGGEGCRCLIL
Met  Arg  Glu  Glu  Thr  Val  Val  Tyr  Glu  Gln  Glu  Glu  Ser  Val 
Ser  His  Gly  Gly  Gly  Lys  His  Arg  Ile  Leu  Ala  Glu  Leu  Ala  Arg
 Val  Glu  Gln  Glu  Val  Ala  Phe  Leu  Glu  Lys  Glu  Leu  Lys  Glu 
Val  Glu  Asn  Thr  Asp  Ile  Val  Ser  Thr  Val  Cys  Glu  Glu  Leu 
Leu  Ser  Val  Ile  Glu  Lys  Gly  Pro  Asp  Pro  Leu  Leu  Pro  Leu  Thr
 Asn  Gly  Pro  Leu  Asn  Leu  Gly  Trp  Asp  Arg  Trp  Phe  Glu  Gly 
Pro  Asn  Gly  Gly  Glu  Gly  Cys  Arg  Cys  Leu  Ile  Leu
$S8&YHFWRUPDS
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$S*(07(DV\YHFWRUFLUFOHPDSDQGVHTXHQFHUHIHUHQFHSRLQWV
$S*(;7YHFWRUPDS
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$S&5,,7232YHFWRUPDSDQGVHTXHQFHUHIHUHQFHSRLQWV
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$S&57177232YHFWRULQFOXGLQJPXOWLSOHFORQLQJVLWHDQGVHTXHQFH
71
$S7UF+LV7232YHFWRULQFOXGLQJPXOWLSOHFORQLQJVLWHDQGVHTXHQFHUHIHUHQFHSRLQWV
72
$S*)3XY9HFWRU0DS
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$**FORQHGLQWRS8&LQ¶Æ ¶GLUHFWLRQ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Molecule: AGG1-pUC18, 3007 bps DNA circular
Notes: AGG1 was PCR amplified containing SacI and EcoRI restriction sites
and blunt end-ligated into pUC18 plasmid in forward direction.
Enzymes:
SacI 11, SbfI 329, NarI 502, SspI 923
PpuMI 202, BspMI 332, SfoI 503, EcoRI 2972
AgeI 254, SphI 335, BbeI 505, SacI    2982
BsmFI 265, HindIII 337, NdeI 554, KpnI   2988
EcoRI 310, KasI 501, AatII 809, XbaI   2999
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%0DSRIFRQVWUXFW$$**FORQHGLQWRS8&LQ¶Æ ¶GLUHFWLRQ
Molecule: AGG1-pUC18, 3007 bps DNA circular
Notes: AGG1 was PCR amplified containing SacI and EcoRI restriction sites
and blunt end-ligated into pUC18 plasmid in forward direction.
Enzymes:
EcoRI 7, SbfI 329, NarI 502, SspI 923
BsmFI   52, BspMI 332, SfoI 503, EcoRI 2972
AgeI 63, SphI 335, BbeI 505, SacI    2982
PpuMI 116, HindIII 337, NdeI 554, KpnI   2988
SacI 314, KasI 501, AatII 809, XbaI 2999
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%0DSRIFRQVWUXFW%$**S*(07(DV\
Molecule: AGG1-pGEMTEasy, 5291 bps DNA circular
Notes: AGG1 was PCR amplified containing SacI and EcoRI restriction sites
and ligated into pGEMTEasy plasmid.
Enzymes:
SacI 11, XhoI 1276, EcoRV       4440
AgeI 254, NotI 1282, HpaI 4496
EcoRI 310, Bsa 2420, KasI 4629
EcoRI 1261, AhdI 2486, NarI 4630
XmaI  1266, MluI 3990, SfoI 4631
SmaI  1268, ApaI 4201, BbeI 4633
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%0DSRIFRQVWUXFW$**S7177232
Molecule: AGG1-pCRT7, 3167 bps DNA circular
Notes: AGG1 was PCR amplified containing no restriction sites and ligated into
pCRT7
plasmid.
Enzymes:
NsiI 1, NdeI 395, XmnI1501, SapI 3106
SphI 3, BamHI 489, ScaI 1620,
BamHI     65, EcoRI 508, BpmI2032,
PstI 280, HinIII 515, BmrI 2061,
XbaI 355, PsiI    1086, PciI 2989,
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%0DSRIFRQVWUXFW$**S7UF+LV7232
Molecule: AGG1-pTrcHisTOPO, 4687 bps DNA circular
Notes: AGG1 was PCR amplified containing no restriction sites and ligated into
pTrcHisTOPO plasmid.
Enzymes:
BamHI 65, BamHI 802, SapI 3149, EcoRV 4366
AgeI 242, EcoRI 821, NdeI 3211, KasI 4555
PstI        280, HindIII 833, SphI 3477, SfoI 4557
NcoI 708, PvuI    1775, MluI 3916,
NheI      746, PciI     3032, ApaI 4127,
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%0DSRIFRQVWUXFW3$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Molecule: AGG1-pGEX4T2, 5260 bps DNA circular
Notes: AGG1 was excised from PCRII-TOPO using EcoRI and XhoI and ligated
into
pGEX4T-2 plasmid which was digested with the same enzymes.
Enzymes:
BamHI 72, SapI 2520, SapI 4657, EcoRI 5260
PstI 287, BclI 3033, PciI 4816, BamHI 5250,
XhoI 305, EcoRV 3469, XmnI 4971, SspI 710,
NotI 311, HpaI 3525, ScaI 5151, SspI 4486,
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All the sequence alignments in the Appendix C were done using SDSC Biology
Workbench.
 &6HTXHQFHDOLJQPHQWRI$**S%6ZLWK$**WRYHULI\WKHVHTXHQFHRI$**
CLUSTAL W (1.81) multiple sequence alignment
AGG1* ------------------------------------------------------------  60
AGG1  CGGGCCCCCCCTCGAGATTTACCCCAGACTCTCTCTGACGTTGTCAGATCTGCGACCTGC
AGG1* ----------ATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGG 120
AGG1  TAGCGAGAGGATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGG
**************************************************
AGG1* CGGGGGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTT 180
AGG1  CGGGGGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTT
************************************************************
AGG1* GGAGAAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCT 240
AGG1  GGAGAAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCT
************************************************************
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AGG1* GCTATCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAA 300
AGG1  GCTATCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAA
************************************************************
AGG1* CTTAGGATGGGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAAT 360
AGG1  CTTAGGATGGGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAAT
************************************************************
AGG1* ACTTTGA----------------------------------------------------- 420
AGG1  ACTTTGATTCGCTAGACAGAGTAATGTGTTACATATACTAGTTTCTTGCTAGGATATCAT
*******
AGG1* ------------------------------------------------------------ 480
AGG1  TTTACATGGGATCCAAAATGGGGCTGTAGCAGAGAAAAAGCGTACAGATTAATGAGCATT
AGG1* ------------------------------------------------------------ 540
AGG1  GGAATTGCATAGAACGGCTTAGTTGCACCTACGTAAACAGTATTATATGTATATGTAATG
AGG1* ------------------------------------------------------------ 600
AGG1  TATGGGATCCGGATCTGACATACGAGTAATGGAGTTTCAGGCTTACAGCTAAAAAAAAAG
AGG1* ------------------------------------------------------------ 660
AGG1  GTAAATCTCGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCCTGCAGCCCGGGGGA
AGG1* ----------------------------------------
AGG1  TCCACTAGTTCTAGAGCGGCCGCCACCGCGGTGGAGCTCC
&6HTXHQFLQJUHVXOWRI$XS$**FORQHGLQWRS8&LQ¶Æ ¶GLUHFWLRQ
CLUSTAL W (1.81) multiple sequence alignment
A1up  GTAACACGGCCGTGCCAGCTTGCATGCCTGCAGGTCTATATAGAGCTCATGCGAGAGGAA 60
AGG1* ------------------------------------------------ATGCGAGAGGAA
************
A1up  ACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAAGCACAGGATCCTT 120
AGG1* ACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAAGCACAGGATCCTT
************************************************************
A1up  GCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGAGTTGAAGGAGGTC 180
AGG1* GCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGAGTTGAAGGAGGTC
************************************************************
A1up  GAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGTCATCGAGAAAGGA 240
AGG1* GAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGTCATCGAGAAAGGA
************************************************************
A1up  CCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATGGGACCGGTGGTTT 300
AGG1* CCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATGGGACCGGTGGTTT
82
************************************************************
A1up  GAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGAGAATTCCTGTGCGAC 360
AGG1* GAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGA---------------
*********************************************
A1up  TCTAGAGGATCCCCGGGTACCGAGCTCGAATTCGTAATCATGGTCATAGCTGTTTCCTGT 420
AGG1* ------------------------------------------------------------
A1up  GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAA 480
AGG1* ------------------------------------------------------------
A1up  AGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGC 540
AGG1* ------------------------------------------------------------
A1up  TTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAG 600
AGG1* ------------------------------------------------------------
A1up  AGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGT 660
AGG1* ------------------------------------------------------------
A1up  CGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGA 720
AGG1* ------------------------------------------------------------
A1up  ATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGNCAAAGGCCAGGAACCG 780
AGG1* ------------------------------------------------------------
A1up  TNAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAA 840
AGG1* ------------------------------------------------------------
A1up  AAATCGACGCTCNAGTCAGAAGTGGCGAAACCCGACAGGACTATAANGATACCAGGCGTT 900
AGG1* ------------------------------------------------------------
A1up  TCCC
AGG1* ----
&6HTXHQFLQJUHVXOWRI$GRZQ$**FORQHGLQWRS8&LQ¶Æ ¶GLUHFWLRQ
CLUSTAL W (1.81) multiple sequence alignment
A9downACGCTATGACCTTGATTACGAATTCGAGCTCCGTCCCGGGGATCCTCTAGAGTCTATATA  60
AGG1* ------------------------------------------------------------
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A9downGAGCTCATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGG 120
AGG1* ------ATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGG
******************************************************
A9downGGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAG 180
AGG1* GGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAG
************************************************************
A9downAAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTA 240
AGG1* AAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTA
************************************************************
A9downTCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTA 300
AGG1* TCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTA
************************************************************
A9downGGATGGGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCCGCAGATGCTTAATACTT 360
AGG1*GGATGGGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTT
****************************************** *****************
A9downTGAGAATTCCTGTGCGACCTGCAGGCATGCAAGCTTGGCACTGGCCGTCGTTTTACAACG 420
AGG1* TGA---------------------------------------------------------
***
A9downTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTT 480
AGG1* ------------------------------------------------------------
A9downCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAG 540
AGG1* ------------------------------------------------------------
A9downCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTC 600
AGG1* ------------------------------------------------------------
A9downACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCC 660
AGG1* ------------------------------------------------------------
A9downCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGC 720
AGG1* ------------------------------------------------------------
A9downTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATC 780
AGG1* ------------------------------------------------------------
A9downACCGAAACGCGCGAGACGANAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCAT 840
AGG1* ------------------------------------------------------------
A9downGATAATAATGGTTTCTTAGACGTCNAGTGGCACTTTTTCGGGGAATGTGCGCGGAAC
AGG1* ------------------------------------------------
84
&6HTXHQFLQJUHVXOWRI%S*(07(DV\$**
CLUSTAL W (1.81) multiple sequence alignment
B2    AATGGGCCGACGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTATATA  60
AGG1* ------------------------------------------------------------
B2    GAGCTCATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGG 120
AGG1* ------ATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGG
******************************************************
B2    GGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAG 180
AGG1* GGCAAGCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAG
************************************************************
B2    AAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTA 240
AGG1* AAAGAGTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTA
************************************************************
B2    TCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTA 300
AGG1* TCTGTCATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTA
************************************************************
B2    GGATGGGACCGGTGGTTTGACGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTT 360
AGG1* GGATGGGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTT
******************** ***************************************
B2    TGAGAATTCCTGTGCAATCACTAGTGAATTCGCGGCCGCCTGCAGGTCGACCATATGGGA 420
AGG1* TGA---------------------------------------------------------
***
B2    GAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTG 480
AGG1* ------------------------------------------------------------
B2    GCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACAC 540
AGG1* ------------------------------------------------------------
B2    AACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC 600
AGG1* ------------------------------------------------------------
B2    ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG 660
AGG1* ------------------------------------------------------------
B2    CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCT 720
AGG1* ------------------------------------------------------------
B2    TCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCNA 780
AGG1* ------------------------------------------------------------
B2    CTCAAGGCNGGTATACGGTTATCCACAGAATCAGGNNGATACGCANGAAAAGACATGTGA 840
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AGG1* ------------------------------------------------------------
B2    GCANAGGCCAGCANNAGGGCAGAACCCGTAAAGGGCGCGTGCTGGCGTTTTCCCATAGCT 900
AGG1* ------------------------------------------------------------
B2    CCGCCCCCTG
AGG1* ----------
&6HTXHQFLQJUHVXOWRIS7177232H[SUHVVLRQ$**
CLUSTAL W (1.81) multiple sequence alignment
13    ANCCAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATG  60
AGG1* ------------------------------------------------------------
13    CGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAAATG 120
AGG1* ------------------------------------------------------------
13    GGTCGGGATCTGTACGACGATGACGATAAGGATCCAACCCTTCAAAGTATTAAGCATCTG 180
AGG1* ------------------------------------------------------------
13    CAGCCTTCTCCTCCATTTGGTCCTTCAAACCACCGGTCCCATCCTAAGTTCAAAGGTCCA 240
AGG1* ---------------------------------------------ATGCGAGAGGAAACT
* * * * *
13    TTGGTTAGTGGCAACAGAGGATCGGGTCCTTTCT-CGATGACAGATAGCAGCTCCTCACA 300
AGG1* GTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAAGCACAGGATCCTTGCA
***** * * * ** * * ** * ** * ** * * **** **
13    CACGGTTGATACAATATCTGTGTTCTCGACCTCCTTCAACTCTTTCTCCAAGAAAGCGAC 360
AGG1* GAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGAGTTGAAGGAGGTCGAG
* * * * * *** ** * * * * ** ***
13    TTCCTGTTCAACGCGGGCAAGCTCTGCAAGGATCCTGTGCTTGCCCCCGCCGTGAGAAAC 420
AGG1* AACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGTCATCGA-GAAAGGACC
* * * * * ** **** * * ** * ** * ** * *
13    AGACTCCTCCTGCTCGTAAACCACAGTTTCCTCTCGCATAAGGGCGAATTCGAAGCTTGA 480
AGG1* CGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATGGGACCGGTGGTTTGA
** * * * ***** * * * * ** * * * * * ****
13    TCCGGCTGCTAACAAAGCCCGAAAGGAAGCTG-AGTTGGCTGCTGCCACCGCTGAGCAAT 540
AGG1* AG--------GACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGA---------
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** ** ** * **** ** ** * * *
13    AACTAGCATAACCCCTTGGGGCCTCTAAACGGG
AGG1* ---------------------------------
&6HTXHQFLQJUHVXOWRIS7UF+LV7232$**
CLUSTAL W (1.81) multiple sequence alignment
3-2   TNATANGGAGGAATNAATTNTGGGGGGTTNTCTCATCTCTCATCATGGTATGGCTAGCAT  60
AGG1* ------------------------------------------------------------
3-2   GACTGGTGGACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGATCCAACCCT 120
AGG1* ------------------------------------------------------------
3-2   TATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAA 180
AGG1* -ATGCGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAA
***********************************************************
3-2   GCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGA 240
AGG1* GCACAGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGA
************************************************************
3-2   GTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGT 300
AGG1* GTTGAAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGT
************************************************************
3-2   CATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATG 360
AGG1* CATCGAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATG
************************************************************
3-2   GGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGAAA 420
AGG1* GGACCGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGA--
**********************************************************
3-2   GGGCGAATTCGAAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCAGCCTGATACAGA 480
AGG1* ------------------------------------------------------------
3-2   TTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGG 540
AGG1* ------------------------------------------------------------
3-2   TGGTCCCACCTGACCCCATGCCGAACTCAGAAGTG
AGG1* -----------------------------------
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S*(;7$**
CLUSTAL W (1.81) multiple sequence alignment
P-A   TGGGCGGACCATCCCTCCAAAATCGGATCTGGTTCCGCGTGGATCCCCAGGAATTCCCTG  60
AGG1* ---------------------------------------------------------ATG
**
P-A   CGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAAGCAC 120
AGG1* CGAGAGGAAACTGTGGTTTACGAGCAGGAGGAGTCTGTTTCTCACGGCGGGGGCAAGCAC
************************************************************
P-A   AGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGAGTTG 180
AGG1* AGGATCCTTGCAGAGCTTGCCCGCGTTGAACAGGAAGTCGCTTTCTTGGAGAAAGAGTTG
************************************************************
P-A   AAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGTCATC 240
AGG1* AAGGAGGTCGAGAACACAGATATTGTATCAACCGTGTGTGAGGAGCTGCTATCTGTCATC
************************************************************
P-A   GAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATGGGAC 300
AGG1* GAGAAAGGACCCGATCCTCTGTTGCCACTAACCAATGGACCTTTGAACTTAGGATGGGAC
************************************************************
P-A   CGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGACTCGAG 360
AGG1* CGGTGGTTTGAAGGACCAAATGGAGGAGAAGGCTGCAGATGCTTAATACTTTGA------
******************************************************
P-A   CGGCCGCATCGTGACTGACTGACGATCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAAC 420
AGG1* ------------------------------------------------------------
P-A   CTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGC 480
AGG1* ------------------------------------------------------------
P-A   AGACAAGCCCGTCAGGGCGCGTCANCGGGTGTTGGCGGGNTGCGGGGCGCAGCCATGACC 540
AGG1* ------------------------------------------------------------
P-A   CAGTCACGTAGCGATAGCGGAGTGTATAATTC
AGG1* --------------------------------
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Aotuclave: Hirayama, Hiclave HV-110, JAPAN
Certoclav, Table Top Autoclave CV-EL-12L, AUSTRIA
Balance: Sartorius, BP211D, GERMANY
Sartorius, BP221S, GERMANY
Sartorius, BP610, GERMANY
Schimadzu, Libror EB-3200 HU, JAPAN
Centrifuge: Eppendorf, 5415C, GERMANY
Eppendorf, 5415D, GERMANY
89
Eppendorf, 5415R, GERMANY
Kendro Lab. Prod., Heraeus Multifuge 3L, GERMANY
Hitachi, Sorvall RC5C Plus, USA
Hitachi, Sorvall Discovery 100 SE, USA
Deepfreeze: -70 C, Kendro Lab. Prod., Heraeus Hfu486 Basic, GERMANY
-20 C, Bosch, TÜRK YE
Distilled water: Millipore, Elix-S, FRANCE
Millipore, MilliQ Academic, FRANCE
Electrophoresis: Biogen Inc., USA
Biorad Inc., USA
Gel Documentation: UVITEC, UVIdoc Gel Documentation System, UK
Biorad, UV-Transilluminator 2000, USA
Ice Machine: Scotsman Inc., AF20, USA
Incubator: Memmert, Model 300, GERMANY
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Memmert, Model 600, GERMANY
Laminar Flow: Kendro Lab. Prod., Heraus, HeraSafe HS12, GERMANY
Magnetic Stirrer: VELP Scientifica, ARE Hetaing Magnetic Stirrer, ITALY
VELP Scientifica, Microstirrer, ITALY
Microliter Pipette: Gilson, Pipetman, FRANCE
Metler Toledo, Volumate, USA
Microwave oven: Bosch, TÜRK YE
pH meter: WTW, pH540 GLP Multical®, GERMANY
Power Supply: Biorad, PowerPac 300, USA
Wealtec, Elite 3000, USA
Refrigerator: +4ºC, Bosch, TÜRK YE
Shaker: Forma Scientific, Orbital Shaker 4520, USA
GFL, Shaker 3011, USA
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New Brunswick Sci., InnovaTM 4330, USA
Spectrophotometer: Schimadzu, UV-1208, JAPAN
Schimadzu, UV-3150, JAPAN
Secoman, Anthelie Advanced, ITALY
Speed Vacuum: Savant, Speed Vac® Plus Sc100A, USA
Savant, Refrigerated Vapor Trap RVT 400, USA
Thermocycler: Eppendorf, Mastercycler Gradient, GERMANY
Vacuum: Heto, MasterJet Sue 300Q, DENMARK
Waterbath: Huber, Polystat cc1, GERMANY
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